News Sentiment

ELOX sentiment intelligence

Eloxx Pharmaceuticals, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 34 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 11.81 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 28

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-6.0% over one week, -12.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Price to book forward of Eloxx Pharmaceuticals, Inc. – NASDAQ:ELOX

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -6.0% Price reacting lower
Trend fit Trend inactive -12.6% over four weeks
Fair value -7.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 29
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 28
Industry context 6
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 6
Market source 6
TradingKey 4
TradingView 3
Investopedia 2
ad-hoc-news.de 1
Benzinga España 1
Finviz 1

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 10
Deals and strategy 3
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-34 of 34